Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events new study assesses financial impact new drug recommendations pbac
… are suitable - Select an instrument or determine if a new one is needed - Plan for the collection of utility data … and standard gamble - Capture utility data real-time, as events occur, via mobile technology solutions (e.g., … the requirements of agencies such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let …
… 2023 Value Assessment Framework Updates: How Might Changes Impact Pharmaceutical Companies? Share on: July 28, 2023 … Health Economics with RTI Health Solutions. ICER’s New Value Assessment Framework On June 5, 2023, the Institute … demographic information ahead of first availability of the study outcomes Strengthen trial recruitment strategy to …
… New System for Ear Tube Insertion Approved by FDA: General … in an operating room (OR). In November, the U.S. Food and Drug Administration (FDA) granted approval to Tusker … with Tusker Medical to design and implement a preference study to understand parents’ willingness to choose the Tula …
… Chris Simmons Named New Leader of RTI Health Solutions Share on: January 11, … needs, enhance our solution offerings, and increase our impact on patient well-being. “Chris has an ambitious vision … Simmons is a CPA with more than 30 years of experience in financial and operational positions, with particular focus on …
… help you identify gaps to inform a strategy for possible new studies to include in your clinical development program … are not usually measured together in the same studies or study populations, and are not often gathered in a real-world …
… New Patient-Reported Outcomes Diary for Rare Acromegaly … experiences with the symptoms, treatment outcomes, and impact on quality of life of health conditions are known as … outcomes (PROs) and are a major focus of ongoing drug development. The US Food and Drug Administration (FDA) …
… New FDA Draft Guidance For Evaluating Patient-Reported … be considered when evaluating PROs intended to support drug submissions as well as medical devices. The draft offers … differences between the population in the pivotal clinical study (e.g., stage of disease) and the population that …
… meta-analyses to synthesize the evidence quantitatively, new information can be generated that was not available from … effect models Meta-regression techniques to assess the impact of covariates Methods to assess heterogeneity It is … of different techniques may be required within a single study. We are able to fit MTCs to wide variety of different …
… Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. … We can help you assess the relevance of a current or new product’s attributes across its lifecycle—including efficacy, safety, impact on quality of life and functional status, dosing …
… Randomization Interim and final data analyses Clinical Study Reports (CSR) Support for regulatory agency submissions … to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare Resource Utilization Our … outcomes Assessing burden of disease Exploring the impact of missing data We will collaborate with you to …